Publication | Open Access
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials
100
Citations
23
References
2021
Year
IL-1 blockade with anakinra for 14 days in patients with STEMI reduces the incidence of new-onset HF or hospitalization for HF at 1 year following STEMI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1